NCT07677319

Brief Summary

The hypothesis is that the preoperative Clinical Frailty Score (CFS) is a predictive factor for a loss in quality-adjusted life years (QALYs) one year after emergency cardiac surgery under cardiopulmonary bypass (CPB) in patients aged 75 years and older.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
265

participants targeted

Target at P75+ for not_applicable

Timeline
29mo left

Started Dec 2025

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress22%
Dec 2025Dec 2028

Study Start

First participant enrolled

December 3, 2025

Completed
7 months until next milestone

First Submitted

Initial submission to the registry

June 18, 2026

Completed
12 days until next milestone

First Posted

Study publicly available on registry

June 30, 2026

Completed
2.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 3, 2028

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 3, 2028

Last Updated

June 30, 2026

Status Verified

June 1, 2026

Enrollment Period

3 years

First QC Date

June 18, 2026

Last Update Submit

June 29, 2026

Conditions

Keywords

FrailtyElderlyCardiac SurgeryCardio-pulmonary BypassQALYsClinical Frailty ScaleEuroQol, postoperative

Outcome Measures

Primary Outcomes (1)

  • Quality-Adjusted Life Years (QALYs) according to preoperative frailty status

    QALYs over the 12-month follow-up will be estimated from EQ-5D-5L utility scores collected at baseline, Month 3, Month 6, and Month 12 together with survival data, and compared between participants with preoperative frailty (Clinical Frailty Scale ≥4) and those without frailty (Clinical Frailty Scale \<4), with adjustment for EuroSCORE II.

    Month 12

Secondary Outcomes (11)

  • Postoperative complications

    From surgery through,Day 28

  • All-cause mortality

    Through Month 12

  • EQ-5D-5L Utility Index

    Baseline, Month 3, Month 6, and Month 12

  • Dialysis dependence

    Month 3, Month 6, and Month 12

  • Length of intensive care unit stay

    From ICU admission to ICU discharge (assessed up to Day 28)

  • +6 more secondary outcomes

Study Arms (2)

Frail group

EXPERIMENTAL

Patients with Clinical Frailty Score CFS ≥ 4

Other: Phone Calls

Non-frail group

EXPERIMENTAL

Patients with Clinical Frailty Score CFS \< 4

Other: Phone Calls

Interventions

Phone calls will be made at 3, 6, and 12 months to report quality of life scores (EuroQol EQ 5D-5L) and other postoperative data

Frail groupNon-frail group

Eligibility Criteria

Age75 Years+
Sexall
Healthy VolunteersNo
Age GroupsOlder Adult (65+)

You may qualify if:

  • Patients aged ≥ 75 years who are affiliated with or beneficiaries of a social security scheme and undergoing emergency cardiac surgery under cardiopulmonary bypass, either immediate or urgent (relative) :
  • Immediate emergency surgery: intervention performed before the start of the next working day following the decision to operate,
  • Urgent (relative) emergency surgery: patients not admitted electively for surgery but requiring an intervention during the current hospital stay for medical reasons, and who cannot be discharged without undergoing a definitive procedure

You may not qualify if:

  • Patients requiring preoperative cardiopulmonary resuscitation
  • Scheduled (elective) surgery
  • Lack of informed consent
  • Individuals under legal guardianship or judicial protection
  • Individuals participating in another interventional research protocol

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Hospital, Bordeaux

Bordeaux, France, 33076, France

RECRUITING

MeSH Terms

Conditions

Frailty

Condition Hierarchy (Ancestors)

Pathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Simon CARRE, MD

    University Hospital, Bordeaux

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 18, 2026

First Posted

June 30, 2026

Study Start

December 3, 2025

Primary Completion (Estimated)

December 3, 2028

Study Completion (Estimated)

December 3, 2028

Last Updated

June 30, 2026

Record last verified: 2026-06

Data Sharing

IPD Sharing
Will not share

Locations